Company Overview
MitoSciences was founded in the summer of 2003 by Dr. Roderick Capaldi and Dr. Michael Marusich with the mission of advancing mitochondrial research, and in particular, efforts to understand the role of the organelle in human diseases.
The Company has produced and continues to add to the world's largest collection of anti-mitochondrial monoclonal antibodies. These antibodies are being sold for life sciences research, developed into kits for drug discovery and drug toxicity studies, as well as being developed into tools for the diagnosis of the many mitochondrial-related diseases and for diagnosing mitochondrial toxicity from HAART.
The Company is located in the Riverfront Research Park across from the University of Oregon.
|
|
CART
